Comparison of Contrast-Enhanced Mammography With Conventional Digital Mammography in Breast Cancer Screening: A Pilot Study.


Journal

Journal of the American College of Radiology : JACR
ISSN: 1558-349X
Titre abrégé: J Am Coll Radiol
Pays: United States
ID NLM: 101190326

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 09 01 2019
revised: 10 04 2019
accepted: 10 04 2019
pubmed: 17 5 2019
medline: 18 8 2020
entrez: 17 5 2019
Statut: ppublish

Résumé

To perform a pilot evaluation of contrast-enhanced mammography (CEM) for screening to determine whether it can improve accuracy and reader confidence in diagnosis. This institutional review board-approved reader study was comprised of 64 de-identified CEM cases acquired from December 1, 2014, to June 7, 2016, including 48 negative, 5 biopsy-proven benign, and 11 biopsy-proven malignancies. Negative cases were followed for at least 2 years without evidence of cancer. Ten breast imagers of varying experience first rated the low-energy (LE) mammogram and then the CEM examination using BI-RADS categories and a 5-point Likert scale for confidence in diagnosis. There were 635 out a total possible 640 complete reader interpretations included in this analysis. The remaining five incomplete interpretations were excluded. Median sensitivity and specificity improved with the addition of CEM (sensitivity: 0.86 [95% confidence interval {CI}: 0.74-0.95] versus 1 [95% CI: 0.83-1.00], specificity: 0.85 [95% CI: 0.64-0.94] versus 0.88 [95% CI: 0.80-0.92]). Individual receiver operating characteristic curves showed significant improvement with CEM (mean area under the curve increase = 0.056 [95% CI: 0.015-0.097], P = .002). The addition of CEM significantly improved average confidence in 5 of 10 readers when compared with LE (P < .0001) and improved pooled confidence across all tissue density categories, except the almost entirely fatty category. There was a trend toward improved confidence with increasing tissue density with CEM. Degree of background parenchymal enhancement did not affect readers' level of improvement in confidence when interpreting CEM. CEM improved reader performance and confidence compared with viewing only LE, suggesting a role for CEM in breast cancer screening for which larger trials are warranted.

Identifiants

pubmed: 31092346
pii: S1546-1440(19)30440-5
doi: 10.1016/j.jacr.2019.04.007
pii:
doi:

Substances chimiques

Contrast Media 0
Iohexol 4419T9MX03

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1456-1463

Informations de copyright

Copyright © 2019 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Auteurs

Geunwon Kim (G)

Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Jordana Phillips (J)

Beth Israel Deaconess Medical Center, Boston, Massachusetts. Electronic address: jphilli2@bidmc.harvard.edu.

Elodia Cole (E)

American College of Radiology Center for Research Innovation, Philadelphia, Pennsylvania.

Alexander Brook (A)

Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Tejas Mehta (T)

Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Priscilla Slanetz (P)

Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Michael D C Fishman (MDC)

Boston Medical Center, Boston, Massachusetts.

Evguenia Karimova (E)

Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Rashmi Mehta (R)

Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Parisa Lotfi (P)

Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Nancy Resteghini (N)

Atrius Health at Harvard Vanguard Kenmore, Boston, Massachusetts.

Sean Raj (S)

American Radiology Associates, Dallas, Texas.

Vandana Dialani (V)

Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH